Fatal tracheal aspergillosis during rituximab combined chemotherapy for diffuse large B-cell lymphoma that developed after lung transplantation

Transpl Infect Dis. 2015 Dec;17(6):872-5. doi: 10.1111/tid.12458. Epub 2015 Nov 13.

Abstract

Invasive tracheal aspergillosis (ITA) is an infection that is unique to patients who have undergone lung transplantation (LT). Although the activity of this disease often appears on imaging, we encountered a case of ITA that became exacerbated, despite few computed tomography (CT) findings, during rituximab combined chemotherapy for diffuse large B-cell lymphoma. ITA developed during immunosuppressive therapy after LT. Because CT findings may show false-negative results, bronchoscopy is recommended for such cases.

Keywords: bronchoscopy; chemotherapy; invasive tracheal aspergillosis; lung transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Aspergillosis / etiology
  • Aspergillosis / pathology*
  • Fatal Outcome
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / pharmacology
  • Lung Transplantation / adverse effects
  • Lymphoma, B-Cell / drug therapy*
  • Male
  • Rituximab / administration & dosage
  • Rituximab / adverse effects*
  • Rituximab / pharmacology
  • Tracheal Diseases / microbiology*
  • Tracheal Diseases / pathology

Substances

  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Rituximab